Skip to main content
Caplight Logo









Health2Sync

Health2Sync

Private
TaipeiHealthcare & Life Scienceshttps://health2sync.com/

Last Round

Series C

Mar 5, 2025

Total Funding Raised

$29M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Health2Sync is a digital health company that provides a mobile application and cloud-based platform for chronic disease management.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, Healthcare Analytics, Telemedicine, Vertical SaaS, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS, Freemium, Services & Consulting, Hardware Sales, Revenue Share

AI Layer

Application

Keywords

diabetes managementchronic disease managementremote patient monitoringRPMdigital health platformblood glucose trackingpatient management platformdigital therapeuticsDTxtelemedicinepatient engagementhealth data analyticsclinical decision supportinsulin titration softwareVertical SaaSHealth IoTglucose meter sync

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Health2Sync Comparables

Compare Health2Sync with similar companies based on industry and business-model similarity.

Health2Sync comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
TruDoc Healthcare
79%
Glooko
78%
Doctor Diary
78%

Health2Sync Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMar 5, 2025
Series BDec 6, 2017
Series AAug 30, 2016

Health2Sync Investors

Notable investors and investment history

Health2Sync investors
InvestorRounds
Cherubic VenturesSeries A
Taiwania CapitalSeries C
WI Harper GroupSeries B, Series A
Cathay VentureSeries C
ABIES CapitalSeries C
iSeed VenturesSeries A
SparkLabs Global VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2026

    Open roles increased to 71, 2.3x the trailing average.

  • Jul 20, 2026

    Open roles increased to 47, 98% of headcount.

Health2Sync Filings

Explore SEC and related filing metadata, where available.

Health2Sync filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Health2Sync's valuation, stock price, and market status.

Is Health2Sync a public or private company?

Health2Sync is a private company.

What is the current stock price of Health2Sync?

Health2Sync is a private company with no public stock price. No recent secondary market data is available.

How much is Health2Sync worth (valuation)?

Valuation information for Health2Sync is not publicly available.

Can I buy Health2Sync stock?

Health2Sync shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Health2Sync's last funding round?

Health2Sync's most recent funding round was Series C on March 5, 2025.

Who are the main investors in Health2Sync?

Key investors in Health2Sync include Taiwania Capital, WI Harper Group.

Will Health2Sync IPO soon?

No public IPO plans have been announced for Health2Sync.

How can I track Health2Sync secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Health2Sync's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTaipei
Employee Range45
Year Founded2013
Last FundingMar 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?